Low Solubility Peptide Reconstitution recalls
The FDA has published 1 recall involving Low Solubility Peptide Reconstitution since 2025. The latest was reported on 15 Oct 2025. Most were for sterility. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.
Total recalls1since 2025
Last 12 months1reported
Class I00% of total
Ongoing1latest 15 Oct 2025
Recalls per month, last 24 months
click a bar for that monthSeverity split
Class I 0 0%Class II 1 100%Class III 0 0%
Why low solubility peptide reconstitution is recalled
Companies
By year
Ongoing low solubility peptide reconstitution recalls
1 active| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Low Solubility Peptide Reconstitution Solution recalled by GenoGenix | GenoGenix | Sterility | Nationwide |
All low solubility peptide reconstitution recalls, newest first
1 total| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Low Solubility Peptide Reconstitution Solution recalled by GenoGenix | GenoGenix | Sterility | Nationwide |
Should you stop taking Low Solubility Peptide Reconstitution?
Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.